BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu W, Yao J, Zhu X, Qi Y. Nanomedicines: Redefining traditional medicine. Biomed Pharmacother 2021;134:111103. [PMID: 33338747 DOI: 10.1016/j.biopha.2020.111103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Z, Ma L, Luo J. Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis. Pharmaceutics 2021;13:406. [PMID: 33808649 DOI: 10.3390/pharmaceutics13030406] [Reference Citation Analysis]
2 Adeyemi JO, Oriola AO, Onwudiwe DC, Oyedeji AO. Plant Extracts Mediated Metal-Based Nanoparticles: Synthesis and Biological Applications. Biomolecules 2022;12:627. [DOI: 10.3390/biom12050627] [Reference Citation Analysis]
3 Thi TTH, Suys EJA, Lee JS, Nguyen DH, Park KD, Truong NP. Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines (Basel) 2021;9:359. [PMID: 33918072 DOI: 10.3390/vaccines9040359] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
4 Wang L, Su W, Ahmad KZ, Wang X, Zhang T, Yu Y, Chow EK, Ho D, Ding X. Safety evaluation of nanodiamond-doxorubicin complexes in a Naïve Beagle canine model using hematologic, histological, and urine analysis. Nano Res 2022;15:3356-66. [DOI: 10.1007/s12274-021-3867-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Adeyemi JO, Onwudiwe DC, Oyedeji AO. Biogenic Synthesis of CuO, ZnO, and CuO-ZnO Nanoparticles Using Leaf Extracts of Dovyalis caffra and Their Biological Properties. Molecules 2022;27:3206. [PMID: 35630680 DOI: 10.3390/molecules27103206] [Reference Citation Analysis]
6 Shahiwala A. Addressing the gaps in drug-delivery research: from a broader academic perspective to clinical translation. Ther Deliv 2022. [PMID: 35341330 DOI: 10.4155/tde-2022-0009] [Reference Citation Analysis]
7 Zhang X, Zhong L, Zou Z, Liang G, Tang Z, Li K, Tan S, Huang Y, Zhu X. Clinical and Prognostic Pan-Cancer Analysis of N6-Methyladenosine Regulators in Two Types of Hematological Malignancies: A Retrospective Study Based on TCGA and GTEx Databases. Front Oncol 2021;11:623170. [PMID: 33816257 DOI: 10.3389/fonc.2021.623170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tang L, Li J, Zhao Q, Pan T, Zhong H, Wang W. Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery. Pharmaceutics 2021;13:1151. [PMID: 34452113 DOI: 10.3390/pharmaceutics13081151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
9 Wu Z, Li S, Zhu X. The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity. Front Immunol 2021;12:682435. [PMID: 34194437 DOI: 10.3389/fimmu.2021.682435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Perumal K, Ahmad S, Mohd-zahid MH, Wan Hanaffi WN, Z.a. I, Six J, Ferji K, Jaafar J, Boer JC, Plebanski M, Uskoković V, Mohamud R. Nanoparticles and Gut Microbiota in Colorectal Cancer. Front Nanotechnol 2021;3:681760. [DOI: 10.3389/fnano.2021.681760] [Reference Citation Analysis]
11 Massoumi B, Mossavi R, Motamedi S, Derakhshankhah H, Vandghanooni S, Jaymand M. Fabrication of a dual stimuli-responsive magnetic nanohydrogel for delivery of anticancer drugs. Drug Dev Ind Pharm 2021;:1-9. [PMID: 34590962 DOI: 10.1080/03639045.2021.1988099] [Reference Citation Analysis]
12 Alajami HN, Fouad EA, Ashour AE, Kumar A, Yassin AEB. Celecoxib-Loaded Solid Lipid Nanoparticles for Colon Delivery: Formulation Optimization and In Vitro Assessment of Anti-Cancer Activity. Pharmaceutics 2022;14:131. [PMID: 35057027 DOI: 10.3390/pharmaceutics14010131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Allegra A, Gioacchino MD, Tonacci A, Petrarca C, Gangemi S. Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective. Nanomaterials (Basel) 2021;11:2792. [PMID: 34835555 DOI: 10.3390/nano11112792] [Reference Citation Analysis]
14 Medici S, Peana M, Coradduzza D, Zoroddu MA. Gold nanoparticles and cancer: Detection, diagnosis and therapy. Seminars in Cancer Biology 2021. [DOI: 10.1016/j.semcancer.2021.06.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Chen W, Li C, Liang W, Li Y, Zou Z, Xie Y, Liao Y, Yu L, Lin Q, Huang M, Li Z, Zhu X. The Roles of Optogenetics and Technology in Neurobiology: A Review. Front Aging Neurosci 2022;14:867863. [DOI: 10.3389/fnagi.2022.867863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Afsaneh H, Mohammadi R. Microfluidic platforms for the manipulation of cells and particles. Talanta Open 2022. [DOI: 10.1016/j.talo.2022.100092] [Reference Citation Analysis]
17 Mohd Nordin UU, Ahmad N, Salim N, Mohd Yusof NS. Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects. RSC Adv 2021;11:29080-101. [PMID: 35478537 DOI: 10.1039/d1ra06087b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Li T, Mao C, Shen J, Zhou M. Three laws of design for biomedical micro/nanorobots. Nano Today 2022;45:101560. [DOI: 10.1016/j.nantod.2022.101560] [Reference Citation Analysis]
19 Jeswani G, Chablani L, Gupta U, Sahoo RK, Nakhate KT, Ajazuddin. Development and optimization of paclitaxel loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: Exploration of improved hemocompatibility and in vivo kinetics. Biomed Pharmacother 2021;144:112286. [PMID: 34653755 DOI: 10.1016/j.biopha.2021.112286] [Reference Citation Analysis]
20 Amaral M, Cruz N, Rosa A, Nogueira B, Costa D, Santos F, Brazão M, Policarpo P, Mateus R, Kobozev Y, Reis CP. An update of advanced nanoplatforms for Glioblastoma Multiforme Management. EXCLI J 2021;20:1544-70. [PMID: 34924904 DOI: 10.17179/excli2021-4393] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Yuan J, Zhou N, Wu J, Yin T, Jia Y. Ionic liquids as effective additives to enhance the solubility and permeation for puerarin and ferulic acid. RSC Adv 2022;12:3416-22. [DOI: 10.1039/d1ra07080k] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]